Table 5.
Knight-ADRC participants with high-throughput data available distributed by data type and tissue of origin.
| Genomics | Proteomics | Metabolomics & Lipidomics | Methylation | Transcriptomics | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Array-based | WES | WGS | Plasma | CSF | Brain | Plasma | CSF | Brain | Brain | Blood | Brain sRNA | Plasma sRNA | Plasma cfRNA | Blood | Brain | |
| AD | 2,085 | 578 | 928 | 1,266 | 295 | 320 | 1,285 | 286 | 342 | 344 | 15 | 283 | 94 | 134 | 312 | 371 |
| ADAD | 20 | 5 | 16 | 10 | 4 | 6 | 9 | 4 | 7 | 7 | . | 4 | . | . | 2 | 7 |
| ADRD | 531 | 85 | 165 | 349 | 109 | 32 | 359 | 69 | 33 | 34 | . | 3 | 17 | 21 | 359 | 38 |
| Control | 1,999 | 382 | 907 | 1,432 | 642 | 27 | 1,431 | 575 | 29 | 29 | 5 | 34 | 29 | 110 | 801 | 37 |
| DLB | 64 | 10 | 20 | 35 | 4 | 9 | 37 | 4 | 11 | 11 | . | 3 | 13 | 16 | 2 | 14 |
| FTD | 144 | 9 | 38 | 45 | 10 | 18 | 48 | 10 | 19 | 19 | . | 3 | 11 | 12 | 9 | 23 |
| Total | 4,843 | 1,069 | 2,074 | 3,137 | 1,064 | 412 | 3,169 | 948 | 441 | 444 | 20 | 330 | 164 | 293 | 1,485 | 490 |
WES = Whole Exome Sequencing; WGS = Whole Genome Sequencing; CSF = CerebroSpinal Fluid; sRNA = Small RNA; cfRNA = Cell-Free RNA; AD = Alzheimer Disease; ADAD = Autosomal Dominant Alzheimer Disease; ADRD = Alzheimer Disease Related Dementia; DLB = Lewy Body Dementia; FTD = FrontoTemporal Dementia
This table does not include longitudinal sample; for several individuals, more than one time-point (or brain region) is available.